Obstructive sleep apnea as an independent predictor of postoperative delirium and pain: Protocol for an observational study of a surgical cohort [version 2; referees: 2 approved] by Strutz, Patricia et al.




Obstructive sleep apnea as an independent
predictor of postoperative delirium and pain:
Protocol for an observational study of a surgical
cohort [version 2; referees: 2 approved]
Patricia Strutz
Washington University School of Medicine in St. Louis
William Tzeng
Washington University School of Medicine in St. Louis
Brianna Arrington
Washington University School of Medicine in St. Louis
Vanessa Kronzer
Washington University School of Medicine in St. Louis
Sherry McKinnon
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Strutz, Patricia; Tzeng, William; Arrington, Brianna; Kronzer, Vanessa; McKinnon, Sherry; Ben Abdallah, Arbi; Haroutounian, Simon;
and Avidan, Michael S., ,"Obstructive sleep apnea as an independent predictor of postoperative delirium and pain: Protocol for an
observational study of a surgical cohort [version 2; referees: 2 approved]." F1000Research.7,. 328. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6961
Authors
Patricia Strutz, William Tzeng, Brianna Arrington, Vanessa Kronzer, Sherry McKinnon, Arbi Ben Abdallah,
Simon Haroutounian, and Michael S. Avidan





   Obstructive sleep apnea as an independent predictor of
postoperative delirium and pain: protocol for an observational
 study of a surgical cohort [version 2; referees: 2 approved]
Patricia Strutz ,       William Tzeng, Brianna Arrington, Vanessa Kronzer,























































 15 Mar 2018,  :328 (doi:  )First published: 7 10.12688/f1000research.14061.1
 15 Jun 2018,  :328 (doi:  )Latest published: 7 10.12688/f1000research.14061.2
v2
Page 1 of 16
F1000Research 2018, 7:328 Last updated: 29 JUN 2018
  Michael S. Avidan ( )Corresponding author: avidanm@wustl.edu




Draft Preparation;  : Conceptualization, Data Curation, Methodology, Validation, Writing – Review & Editing;  : ProjectKronzer V McKinnon S





 Strutz P, Tzeng W, Arrington B   How to cite this article: et al. Obstructive sleep apnea as an independent predictor of postoperative
   2018,  :328delirium and pain: protocol for an observational study of a surgical cohort [version 2; referees: 2 approved] F1000Research 7
(doi:  )10.12688/f1000research.14061.2








The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 15 Mar 2018,  :328 (doi:  ) First published: 7 10.12688/f1000research.14061.1
Page 2 of 16
F1000Research 2018, 7:328 Last updated: 29 JUN 2018
Introduction
Obstructive sleep apnea (OSA) is the most common form of 
sleep-disordered breathing. OSA is characterized by repetitive, 
functional collapse of the airway leading to cyclical decrements 
or cessations of airflow during sleep1. It is estimated that 20% of 
the general population suffers from OSA2,3, and among adults with 
OSA, up to 75% are unaware of the diagnosis4,5. Of relevance to 
perioperative medicine, there is also a high OSA prevalence in 
surgical patients3. In common with the general population, many 
of these patients are unaware they have OSA6,7. Also of note, 
prevalence of sleep apnea often varies by type of surgery; for 
example, prevalence in the bariatric surgery population is 
estimated to be 70%8,9. OSA prevalence combined with ignorance 
of diagnosis is cause for concern given the wide range of health 
consequences. OSA has been causally implicated in an assortment 
of both acute and chronic disorders. Acutely, OSA has been 
associated with disrupted sleep, tiredness, and episodic hypoxia 
and hypercapnia during sleep10,11. Chronically, OSA has been 
linked to a multitude of co-morbidities, including ischemic heart 
disease and stroke12, hypertension13,14, arrhythmias15,16, aortic 
dissection17,18, chronic fatigue19, pulmonary hypertension20,21, 
diabetes22, and respiratory acidosis with compensatory metabolic 
alkalosis23,24.
OSA is becoming a growing concern in the perioperative period, 
as there is increasing evidence linking OSA to adverse 
postoperative outcomes25,26. For example, following various 
surgical procedures, patients with OSA probably have more 
respiratory, cardiac, and neurologic complications27–30, as well 
as increased postoperative infections31. Unsurprisingly surgical 
patients with OSA therefore have a higher transfer rate to the 
ICU28, increased stay in the ICU31, and increased overall length of 
hospital stay27,28.
Of particular relevance to the research focus of this protocol, 
certain aspects of OSA such as recurrent hypoxemia, systemic 
inflammation, and sleep disruption have been associated with 
altered pain processing and incident delirium32–34. A causal link 
between OSA and delirium would be clinically important given 
the negative outcomes associated with postoperative delirium. 
In the DSM-5, delirium is defined as a disturbance in attention, 
awareness, and cognition that develops over a short period of time 
and over the course of a day, fluctuates in severity35. In older adults, 
the incidence of postoperative delirium ranges from 10–70%, 
depending on the type of surgery36. Patients who experience 
postoperative delirium often require an extended stay in the inten-
sive care unit37, subsequently report decreased quality of life38, 
and might be at increased risk for accidental falls, long-term 
cognitive decline and death after hospital discharge39. Thus, 
postoperative delirium is associated with a considerable burden 
on patients and their families, and an increase to society in the 
overall cost of healthcare40,41.
The reported impact of OSA on postoperative pain and pain 
perception poses further challenges to clinicians and patients. 
Adequate postoperative analgesia is an important component of 
recovery, and pain negatively impacts quality of life. Mechanistic 
evidence in various populations suggests that sleep deprivation 
promotes up-regulation of cytokines42–47, including interleukin-1β, 
interleukin-6, and tumor necrosis factor, all of which might induce 
excessive sensitivity to pain45,48. Consistent with these studies 
clinical evidence, including compelling data from burn vic-
tims, suggests that interrupted and inadequate sleep promotes 
hyperalgesia32–34,49. Furthermore, Khalid et al. showed that 
treatment with continuous positive airway pressure (CPAP) in 
adults with OSA dampened their sensitivity to painful stimuli50. 
Thus, whether or not people with OSA have increased pain sen-
sitivity might to some extent depend on how effectively they are 
treated. To complicate matters further, people with OSA, especially 
if they experience episodic hypoxemia during sleep, reportedly 
have increased susceptibility to the respiratory depressant effects 
of opioid medications51,52. Thus, since opioids are the mainstay of 
therapy for severe postoperative pain, it can be especially difficult 
to provide safe and adequate analgesia to surgical patients with 
OSA.
The objectives of this study are to investigate further the 
relationships between OSA on the one hand, and common 
postoperative complications such as pain and delirium on the 
other hand. We hypothesize that patients with OSA experience 
more severe postoperative pain and have a higher incidence of 
postoperative delirium. We further hypothesize these negative 
outcomes might be mitigated by compliance with OSA treatment.
Protocol
Study design
This protocol describes a retrospective study, investigating the 
relationship between OSA as a risk factor, and postoperative 
delirium and acute postsurgical pain severity as adverse outcomes. 
The three parent studies from which the data are being obtained 
for the current study have all been approved by the Human 
Research Protection Office (HRPO) at Washington University, and 
patients enrolled in all three studies provided written informed 
consent. The HRPO has also provided approval for this current 
study. Data will be aggregated from the Systematic Assessment 
and Targeted Improvement of Services Following Yearlong 
Surgical Outcomes Surveys Study (SATISFY-SOS, NCT02032030); 
the Electroencephalography Guidance of Anesthesia to Alleviate 
Geriatric Syndromes study (ENGAGES, NCT02241655); and 
the Prevention of Delirium and Complications Associated with 
Surgical Treatments study (PODCAST, NCT01690988).
            Amendments from Version 1
This revised protocol addresses the referees’ questions and 
suggestions. Specifically, we provided more information 
regarding the parent studies of this project. Patient selection is 
described in greater detail, and we updated our figures with new 
cohort estimates. We also improved our statistical models with 
suggestions from our reviewers. Our models now incorporate 
adjustments for certain intraoperative medications as well as 
additional comorbidities. Compared to existing literature, one of 
the greatest strengths of this study is the rigorous data collection 
on a broad surgical population. We believe these pre-analytical 
modifications to our models will create a more robust analysis that 
promotes research integrity and reproducibility. 
See referee reports
REVISED
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The PODCAST trial investigated if a single subanesthetic dose of 
ketamine could decrease postoperative incident delirium. There 
was no significant difference in delirium incidence across the 
three treatment groups (placebo, 0.5 mg/kg subanesthetic dose of 
ketamine, 1.0 mg/kg subanesthetic does of ketamine). Additionally, 
there was no apparent difference in reported pain between the 
three groups. However, to be conservative, we will adjust for 
PODCAST group allocation in the regression models in the 
current study. To control for potential effects of the ENGAGES 
intervention (Electroencephalography guided anesthesia vs. 
non-electroencephalography guided anesthesia), we will adjust 
our regression model for this randomization. For greater detail 
regarding the three parent studies, please review previously 
published protocols and literature53–57.
We will include an estimated 1,500 patients in our primary 
analysis. Of the 672 patients randomized for the multicenter 
PODCAST trial, we will include only patients recruited from 
Washington University in St. Louis. The study population will 
be comprised of roughly 100 patients from PODCAST and an 
estimated 1,200 patients from the ENGAGES trial. SATISFY-
SOS is a large scale outcomes survey study, and we will be using 
a subset of roughly 200 patients enrolled in SATISFY-SOS who 
completed daily delirium and pain assessments during hospital 
stay.
Patients ≥ 18 years who underwent general anesthesia for a 
non-neurosurgical inpatient operation at Barnes Jewish Hospital 
in St. Louis, Missouri, from February 2013 to May 2018, will be 
included in our analysis. Patients had a postoperative hospital stay 
of at least one day. The main outcomes of interest will include 
postoperative delirium and pain, assessed daily until postoperative 
day 3. The primary aims of this study are to investigate whether 
OSA is an independent predictor of postoperative delirium and 
acute postsurgical pain severity. We will conduct secondary 
analyses with subgroups to explore whether these associations 
are modified by compliance with OSA treatment. We are also 
interested in evaluating if OSA status is related to postoperative 
opioids given during hospital stay. Thus, we will secondarily 
explore the relationship between OSA risk and total inpatient 
opioid use through postoperative day 3.
This protocol is compliant with published guidelines for obser-
vational study protocols, and the conduct and reporting of this 




(i) Enrollment in the SATISFY-SOS, ENGAGES, or PODCAST 
study;
(ii) Postoperative stay of at least 1 day following surgery at Barnes 
Jewish Hospital





i. Baseline Data. Patients undergoing elective surgery are 
routinely screened at the Center for Preoperative Assessment 
and Planning at Barnes Jewish Hospital in St. Louis, Missouri, 
where detailed medical history is collected and screening 
tests are administered, including the STOP-BANG (Snoring, 
Tiredness, Observed Apnea, High Blood Pressure, Body Mass 
Index>35kg/m2, Age >50, Neck circumference, male Gender) test 
for OSA risk. Baseline characteristics will be extracted via elec-
tronic chart review and will include but are not limited to: age, sex, 
race, ethnicity, smoking history, alcohol use (average per week), 
STOP-BANG criteria, OSA status, and pre-existing medical 
conditions.
ii. Delirium assessment method. Delirium is one of the primary 
outcomes of this study and will be determined using validated 
delirium assessments implemented by a small group of rigorously 
trained research assistants. Delirium for the parent studies was 
assessed predominantly using the Confusion Assessment Method 
(CAM)61,62. If patients were unwilling to complete the full CAM, 
the 3D-CAM was used. The 3D-CAM was developed as a 
method to more efficiently screen patients for delirium. It consists 
of a subset of the questions used in the CAM, as well as CAM 
scoring items that are based on patient behavior (10 cognitive 
testing items, 10 interviewer observations). With this approach, 
the 3D-CAM is intended to only take 3 minutes. For critically 
ill patients, most often found in the intensive care unit, the 
CAM-ICU was used to assess delirium63. 
In the PODCAST trial, Delirium was assessed twice daily 
(morning and afternoon with at least 6 hours between assess-
ments), while in the other trials, delirium was assessed once daily 
between 1pm and 8pm. We will include only the afternoon delir-
ium assessments from PODCAST patients so all patients included 
in analysis were assessed during the same time frame. Although 
patients were assessed for delirium on postoperative day zero at 
least 2 hours after surgery, we will not include this assessment 
because of potential residual general anesthetic effects. We will 
adjust for the use of certain medications, such as preoperative 
midazolam, median volatile anesthetic concentration (converted to 
minimum alveolar concentration [MAC] equivalents), intraopera-
tive ketamine, and intraoperative opioids (converted to morphine 
equivalents in mg).
The presence of delirium will be defined as a positive CAM 
during any postoperative assessment through postoperative day 3. 
In order to qualify for a diagnosis of delirium, the following 
three criteria must be met: 1) either acute onset OR a fluctuating 
course; 2) inattention; and 3) either disorganized thinking OR 
altered level of consciousness. A patient will be considered 
positive for delirium if the patient is recorded to have had 
a single instance of delirium during their postoperative stay.
iii. Pain Assessment Method. Pain during hospital stay will be 
assessed using the Visual Analogue Scale (VAS), a validated 
pain assessment instrument that has been widely used in adult 
populations64,65. Patients are asked to indicate on a line 100mm in 
length the severity of their pain in three different situations: 1) at 
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rest, 2) taking a deep breath or coughing, and 3) moving (sitting 
up, walking, or moving extremities). The patient’s mark is then 
measured with a ruler and recorded in mm. For our analysis, we 
will incorporate the highest pain score recorded on any 
postoperative assessment as our value of interest. As postsurgical 
pain is often dependent on the type of surgery, we will adjust 
for type of surgery in our statistical model, as well as other 
confounding variables described in the methods below.
iv. OSA Classification. For the primary analysis (Figure 1), 
patients will be grouped into one of three categories: high risk of 
OSA (HR-OSA), intermediate risk of OSA (IR-OSA), and low 
risk of OSA (LR-OSA). Patients with a history of a positive poly-
somnography test will be classified as HR-OSA, whereas patients 
with a history of negative polysomnography will be classified as 
LR- OSA. Patients with no history of polysomnography testing 
will be classified into one of the three categories based on 
STOP-BANG screening status. The STOP-Bang question-
naire classifies patients into three commonly accepted categories 
based on scoring: 0–2 indicates low risk of OSA; 3–4 indicates 
intermediate risk; 5–8 indicates high risk66. We will follow these 
guidelines for classifying patients as HR-OSA, IR-OSA, or 
LR-OSA for our primary analysis, and thus likely demonstrate 
important trends between and among groups.
Of note, current literature classifies, often for simplicity, a 
STOP-Bang score of ≥3 as high risk for OSA. However, this can 
obscure analysis, potentially resulting in a falsely weaker asso-
ciation between OSA risk and risk of postoperative adverse 
outcomes. Therefore, we will not group intermediate risk of 
OSA with high risk of OSA. Also, some literature incorporates 
bicarbonate levels to help determine OSA risk. As baseline 
laboratory values are not available for each participant, we 
will not include this component for classifying OSA risk.
For secondary analysis (Figure 2), we will analyze delirium 
incidence and pain severity among five patient groupings: 
confirmed OSA + report using prescribed CPAP, confirmed 
OSA + report not using prescribed CPAP, high risk for OSA 
(STOP-Bang 5–8), intermediate risk for OSA (STOP-Bang 3–4), 
low risk for OSA (STOP-Bang <3). Thus, secondary analysis will 
likely demonstrate if reported CPAP adherence mitigates these 
adverse outcomes.
v. Sample Size. We estimate that we will have data with complete 
outcomes (pain severity and incident delirium) and information on 
OSA status for approximately 1,500 patients. We estimate that 300 
(~20%) of these patients will have incident postoperative delirium. 
We will have patient reported pain outcomes for all participants. 
We will use logistic and linear regression, including potential con-
founder variables, to test for an independent association between 
OSA as a risk factor and postoperative delirium and pain severity 
as outcomes of interest. We estimate that it will be appropriate to 
include up to 25 variables in each of the regression models.
Figure 1. Predicted groupings  for OSA-risk classification  in  the primary analysis, based on previous data  from our preoperative 
assessment clinic7.
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Data management
All electronic data collected during this study, as well as the 
SATISFY-SOS, ENGAGES, and PODCAST databases, are hosted 
on a firewall-secured network server. This server is managed 
and maintained by the IT team of the Department of Anesthesi-
ology, and is securely housed behind two locked doors in the 
departmental offices. The Project Informaticist, Data Manager, 
and Director(s) are the only individuals with full access to these 
password-protected and encrypted databases. Delirium and pain 
assessments are first completed using paper surveys, which are then 
securely stored in locked cabinets within the department. Results 
are entered into a Research Electronic Data Capture (REDCap) tool 
hosted at Washington University School of Medicine in St. Louis67. 
REDCap is a secure, web-based application designed to support 
data capture for research studies, providing: 1) an intuitive interface 
for validated data entry; 2) audit trails for tracking data manipu-
lation and export procedures; 3) automated export procedures 
for seamless data downloads to common statistical packages; 
and 4) procedures for importing data from external sources.
i. Statistical considerations. Continuous variables will be 
graphically evaluated with histograms, boxplots, and q-q plots, 
and numerically with measures of skewness, kurtosis, and 
Kolmogorov-Smirnov tests. Outliers will be excluded, and approxi-
mate normality will be ensured before parametric statistics are 
applied. Perioperative variables will be described with mean ± 
SD, median [IQR], and numbers/proportions, as appropriate. 
Differences in patient and other perioperative factors between 
groups will be evaluated with chi-squared, t-tests, ANOVA, 
Kruskal-Wallis, and/or Wilcoxon-Mann-Whitney tests, as 
appropriate. Multiple imputation methods will be used for 
patients’ missing variables, but participants with missing 
outcomes will be excluded from analysis.
ii. Delirium. Logistic Regression will be used to assess the 
relationship between OSA as a risk factor and incident 
postoperative delirium as an outcome. For our analyses, we will 
include no more than 1 variable for every 10 outcomes. With an 
estimated incident postoperative delirium rate of 20%, we plan 
to include up to 25 pre-specified candidate predictor variables 
in the primary regression models, including the most clinically 
relevant interaction terms. Variables for our primary analysis have 
been selected based on existing evidence, and will likely include: 
OSA status; Age; Sex; Type of Surgery; Charlson Comorbidity 
Index; Procedural Cardiac Risk; ASA physical status; Alcohol 
use; preoperative midazolam use; median volatile anesthetic 
concentration (converted to minimum alveolar concentration 
[MAC] equivalents); intraoperative ketamine use; intraoperative 
opioids (converted to morphine equivalents in mg); and anesthesia 
time in minutes. We will also include a history of any of the 
following comorbidities: COPD or Asthma; Stroke; Dementia 
or Mild Cognitive Impairment; Visual or hearing Impairment; 
Depression or Anxiety; Chronic Pain; and Diabetes Mellitus. 
We hope to include BMI and age independently of the OSA risk 
Figure 2. Predicted groupings for OSA-risk classification in the secondary analysis, based on previous data from our preoperative 
assessment clinic7.
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classification since they are continuous variables, and their 
inclusion in the regressions might improve the models. We 
also hope to include the variable ‘tiredness’ in the models since 
this particular symptom could plausibly independently predict 
both delirium and pain. However, there may be statistical 
limitations (i.e. collinearity) preventing inclusion of some of these 
variables. If so, we may exclude some variables and describe our 
adjustments in the manuscript.
iii. Pain. Linear Regression will be used to examine OSA’s 
potential relationship to postoperative pain. For this analysis, 
the outcome is continuous rather than binary, and will apply to 
all 1,500 patients. It will be reasonable to include up to 25 pre- 
specified candidate predictor variables in the linear regression 
models, including interaction terms. As risk factors for delirium 
and pain are overlapping, the same candidate predictor variables 
will be used in this regression. Sensitivity analyses will be 
conducted to address limitations regarding pain. Since it is 
important to consider delirious patients might be unable to report 
pain accurately, we plan to conduct a sensitivity analysis with pain 
as the outcome, excluding all the patients who were diagnosed 
with postoperative delirium. We also hope to explore any potential 
relationship between OSA risk and total postoperative opioids 
given during hospital stay (expressed as morphine equivalents in 
mg). Additionally, since our primary analysis will not consider 
duration of severe pain or distinguish between rest and provoked 
pain, we plan to conduct a sensitivity analysis with median 
provoked pain during hospital stay (up to postoperative day 3) 
as the outcome. The responses to two VAS questions (pain when 
(i) taking a deep breath or coughing, and (ii) moving (sitting up, 
walking, or moving extremities)) will be compiled to represent 
provoked pain during hospital stay.
Anticipated results
We expect that patients with a high risk of OSA will experience 
greater postoperative pain severity, and have a higher risk for 
postoperative delirium following surgical procedures. For our 
secondary analyses, we propose that these adverse outcomes 
might be modified by compliance with CPAP treatment. We 
predict patients with diagnosed OSA who do not use pre-
scribed CPAP will experience a higher incidence of delirium and 
increased pain. We also expect a step-wise increase in these 
adverse outcomes (delirium incidence and pain severity) when 
analyzing patients based on their STOP-Bang assessment groups 
(high risk vs. intermediate risk vs. low risk).
Discussion
OSA is a common and frequently undiagnosed perioperative 
problem. This observational study will help to clarify whether or 
not OSA is an independent predictor of postoperative incident 
delirium and acute postoperative pain. Secondary analyses 
may show if these adverse outcomes might be modified by 
compliance with OSA treatment.
In this study, we will attempt to replicate the reported finding 
showing that OSA is an independent predictor of postoperative 
delirium and acute postsurgical pain severity32–34. This study will 
have important strengths compared to the existing literature; 
most notably the database including routine structured preop-
erative screening for OSA, and postoperative delirium and pain 
assessments on a broad surgical population. The researchers who 
collected data for this study were all expertly trained in administer-
ing delirium and pain assessments. In an effort to improve meth-
odological rigor, we have pre-specified independent variables for 
regression models, and have described our statistical analyses.
This study will also have important limitations. Although we 
will have thorough medical histories routinely collected from 
preoperative clinic assessments, we will not know severity of OSA 
or other comorbidities. In common with any observational study, 
this study will be unable to distinguish association from causa-
tion. In particular, if we do find in this study that OSA is associ-
ated with either increased delirium incidence or pain severity, we 
will not be able to determine (i) whether OSA is causally impli-
cated or (ii) whether there is another explanatory factor associated 
with both OSA and these outcomes. Regarding the outcome of 
delirium, this study will address on the crude association with 
incident delirium as a binary outcome. It might be more important 
to focus on either the duration or severity of delirium. Regard-
ing pain, it is important to consider that delirious patients might 
be unable to report pain accurately. This limitation is common to 
all studies evaluating postoperative pain. To mitigate this to an 
extent, we plan to conduct a sensitivity analysis with highest VAS 
pain score as the outcome, excluding all the patients who were 
diagnosed with postoperative delirium. Also in relation to 
pain, our primary outcome will be most severe pain reported in 
postoperative days 1–3. This approach will not consider duration 
of severe pain or distinguish between rest and provoked pain. To 
mitigate this to an extent, we plan to conduct a sensitivity analysis 
exploring median provoked pain through postoperative day 3 as 
the outcome. Additionally, it will be important to include analge-
sic medication as potential confounders in the regression analyses, 
and accurate data on these might not be available.
In conclusion, while likely providing stronger evidence regarding 
the impact of OSA on postoperative delirium and pain, this study 
might also discern interventional strategies for treatment and 
prevention. For example, in relation to delirium, we could test 
perioperative delirium prevention bundles in patients with OSA 
or we could investigate whether preoperative initiation of CPAP 
treatment decreases this complication. The role of CPAP therapy 
in relation to improved analgesia should also be clarified. 
Regarding pain, we could further develop analgesic plans 
especially for surgical patients with OSA, such as emphasizing 
regional analgesia or non-opioid analgesics. We could also 
implement procedures intended to improve the safety of patients 
with OSA receiving respiratory depressant medications in the 
perioperative period. With emerging knowledge about biased 
signaling with opioids68, it is possible that certain opioids 
(e.g. morphine) are safer than others (e.g., Fentanyl) for patients 
with OSA in terms of their propensity to provide analgesia 
rather than to cause respiratory depression. We hope to use 
the foundational work proposed in this observational study to 
guide the design of such trials and clinical plans, with the 
goals of reducing postoperative delirium and acute postoperative 
pain severity for the large number of patients at risk due to OSA.
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Thank you, Dr. Eikermann and Dr. Timm, for your feedback on our study protocol.  We sincerely
appreciate your time and thoughtful suggestions.  Along with submitting our revised protocol, we





We have included more details about our cohort under the “Study Design” section.  Briefly, yes the
patients are studied from a historical cohort, and we have improved our model to adjust for
randomization group from the previously studied interventions.  Although the PODCAST trial did





We have added details regarding our delirium assessments under “Data collection: Delirium
assessment method.”  All POD 1 assessments were administered in the afternoon between 1pm
and 8pm. Patients were assessed on POD 0; however we are excluding these assessments
because of potential lingering general anesthetic effects. We are also now adjusting our model for
the use of certain medications, such as preoperative midazolam, median volatile anesthetic
concentration (converted to minimum alveolar concentration [MAC] equivalents), intraoperative






Thank you for this suggestion! We are unable to incorporate the SPOSA score for this cohort
because of limiting factors with electronic medical data.  However, we are excited about this new
model and the ability to classify OSA risk in larger cohorts, especially when neck circumference is





We have included more details about patient flow under the “Study Design” section. We now hope
to include all 1200 patients from the ENGAGES trial.  Of the ~600 patients in the PODCAST study,
we will include those patients recruited through Washington University in St. Louis (roughly 100
patients).  Although SATISFY-SOS aims to enroll a large number of patients, only 200 of those





The data to classify patient reported CPAP use comes from routine questions that are part of our
OSA screening done in our pre-operative clinic. Specifically, we ask patients who have been
diagnosed with OSA if they are prescribed CPAP (or an alternative OSA PAP treatment) and if they
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diagnosed with OSA if they are prescribed CPAP (or an alternative OSA PAP treatment) and if they
use their CPAP. Unfortunately in this study, we are unable to account for patients with undiagnosed
OSA who may have been treated with CPAP for other respiratory diseases. This has the potential
to decrease any difference in outcomes we may see between the study groups and bias our
findings towards the null hypothesis (H0= no difference in outcomes between the groups).  This
would be a limitation of our secondary sub-group analysis, which we would discuss in our















Thank you for these suggestions- they have helped us improve our statistical models. We will
include COPD, asthma, and anesthesia time in minutes; however we will not be able to include
history of neuromuscular disorders or pre-prescribed drugs. Additionally, we will adjust our models
for medications used during surgery. We are still hopeful to include age and BMI, but collinearity
may prevent us from incorporating these variables independently. We will explain any statistical
limitations in the manuscript. Again, thank you for your time and your suggestions!  
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Thank you, Dr. Wong and Dr. Chung, for your feedback on our study protocol.  We sincerely
appreciate your time and thoughtful suggestions.  Along with submitting our revised protocol, we
would like to directly address some suggestions.  We will be including type of surgery as an
independent variable in our regression models, and we will also be adjusting our analysis for a
history of chronic pain.  We agree with your suggestion to report hospital CPAP use. 
Unfortunately, we do not have that information available to us and are unable to provide a more
robust measure of CPAP adherence- a limitation we would discuss in our manuscript. Again, thank
you for your time.  
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